Comment on

• A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis.

  Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL, Sreih AG, Spiera R, McAlear CA, Warrington KJ, Pagnoux C, McKinnon K, Forbess LJ, Hoffman GS, Borchin R, Krischer JP, Merkel PA; Vasculitis Clinical Research Consortium. Langford CA, et al. Arthritis Rheumatol. 2017 Apr;69(4):837-845. doi: 10.1002/art.40044. Epub 2017 Mar 3. Arthritis Rheumatol. 2017. PMID: 28133925 Free PMC article. Clinical Trial.
• A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis.

  Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL, Sreih AG, Spiera R, McAlear CA, Warrington KJ, Pagnoux C, McKinnon K, Forbess LJ, Hoffman GS, Borchin R, Krischer JP, Merkel PA; Vasculitis Clinical Research Consortium. Langford CA, et al. Arthritis Rheumatol. 2017 Apr;69(4):846-853. doi: 10.1002/art.40037. Epub 2017 Mar 8. Arthritis Rheumatol. 2017. PMID: 28133931 Free PMC article. Clinical Trial.
• Personalized Biologic Therapy for Large Vessel Vasculitis: Comment on the Articles by Langford et al.

  Moiseev S, Novikov P, Smitienko I. Moiseev S, et al. Arthritis Rheumatol. 2017 Jul;69(7):1504-1505. doi: 10.1002/art.40106. Epub 2017 May 10. Arthritis Rheumatol. 2017. PMID: 28324916 No abstract available.
• Abatacept as Adjunctive Therapy for the Treatment of Giant Cell Arteritis: Comment on the Article by Langford et al.

  de Boysson H, Aouba A. de Boysson H, et al. Arthritis Rheumatol. 2017 Jul;69(7):1504. doi: 10.1002/art.40105. Epub 2017 May 10. Arthritis Rheumatol. 2017. PMID: 28324917 No abstract available.